Efficient detection of recurrent translocation-associated fusion genes is of critical importance for the diagnosis, prognosis and post-therapeutic monitoring of many leukemias. Typically, the presence of such translocations is revealed by RT-PCR technique, followed by Southern blot hybridization to ensure specificity of the PCR product. Though widely employed, post-PCR analysis of this type is relatively laborious and time-intensive. As a departure from standard analytic approaches, we have developed a robust novel method combining both high specificity and sensitivity, based on polystyrene bead capture of fluorescently labeled PCR products, with subsequent analysis by flow cytometry. Results from cell line and patient sample evaluations indicate that this method may be easily incorporated into the diagnostic molecular laboratory as a rapid and cost-effective alternative to currently employed techniques.
Introduction
Recurrent chromosomal translocations characterize a substantial proportion of the acute myeloid and lymphoid leukemias, resulting in the formation of unique fusion genes. The identification of particular fusion gene abnormalities is of considerable diagnostic and prognostic importance. [1] [2] [3] [4] In addition, given the 'leukemia-specific' nature of these transcribed genes, the corresponding chimeric mRNAs can serve as valuable markers for sensitive minimal residual disease monitoring following therapeutic induction. 1, 5, 6 Detection of an individual translocation fusion gene abnormality is commonly accomplished by reverse-transcription polymerase chain reaction (RT-PCR) amplification encompassing the junctional region of the chimeric mRNA molecule, followed by detection of the specific PCR products by gel electrophoresis. Although interpretation of electrophoretic band patterns may often be sufficient, the production of nonspecific PCR amplicons can frequently create substantial difficulty in accurate analysis. To alleviate this problem, many laboratories employ an additional Southern blot hybridization step, using a specific oligonucleotide probe with isotopic or non-isotopic detection on a nylon membrane. 7 Although specificity is greatly enhanced using blot and probe methods, these additional maneuvers are technically more laborious, costly and time-consuming. In order to retain the specificity of probe hybridization detection of target PCR amplicons and simultaneously reduce the technical complexity of post-PCR analysis in the diagnostic setting, we have developed a novel approach involving capture of fluorescent PCR product and probe complexes on to polystyrene microsphere beads, followed by rapid analysis in a flow cytometer. By optimizing several aspects of both the PCR and post-PCR analysis, we have developed a specific and sensitive assay, with additional substantial benefits in labor and cost reduction.
Materials and methods

Cell lines and patient samples
Cell lines K562, BV173 and SUP-B15, carrying the t(9;22)-associated BCR-ABL fusion transcripts B3-A2, B2-A2, and E1-A2, respectively, were obtained from the American Type Culture Collection (ATCC). Cell line 697 harbors the t(1;19)/E2A-PBX1 fusion and was a generous gift of Dr D LeBrun, Queen's University, Canada. For evaluation of patient samples, excess material (ie banked cells or RNA) retained at UNM was identified, including cases with and without the translocation fusion genes of interest. For dilutional sensitivity studies, either serial RNA-to-RNA or cell-to-cell dilutions were prepared using the positive control cell lines and a fusion gene negative cell source. The research protocol was approved by the UNM Human Research Review Committee.
RNA isolation and reverse-transcription polymerase chain reaction
RNA isolation was performed using the RNeasy Mini Kit (Qiagen, Santa Clarita, CA, USA) according to the manufacturer's protocol. Single tube RT-PCR was carried out using the OneStep RT-PCR Kit (Qiagen). Briefly, 1 g of total RNA was reverse transcribed and subjected to PCR amplification in a 50 l reaction volume containing 1 × OneStep RT-PCR Buffer, 400 M of each dNTP, 30 pmol (0.6 M) of each primer and 2 l OneStep RT-PCR enzyme mix. RT-PCR was performed in a GeneAmp model 9700 thermal cycler (Perkin Elmer, Foster City, CA, USA) using the following parameters: (RT step) 50°C for 30 min, then (PCR step) 95°C for 15 min (for 'hot start'), 35 cycles of 95°C for 30 s, 58-62°C for 30 s, 72°C for 1 min, final extension at 72°C for 10 min, followed by cooling to 4°C. For each primer set employed in the fluorescent detection protocol, the reverse (downstream) primer was labeled with biotin at the 5Ј end to enable post-PCR analysis (see below). One PCR was carried out to detect the t(1;19)/ E2A-PBX1 fusion. For the t(9;22)/BCR-ABL, one single tube polymerase chain reaction was performed, using B2 and E1 forward primers with the A2 reverse primer, to detect the major breakpoint region (M-BCR) B2-A2 and B3-A2 fusions, as well as the minor breakpoint cluster region (m-BCR) E1-A2 fusion, respectively. Negative controls (non-specific RNA or no RNA template) were utilized in each run to assess for contamination. To confirm RNA integrity and reverse transcription efficacy, a segment of beta2-microglobulin (beta2-MCG) or E2A gene transcript was concurrently amplified for each sample and detected by agarose gel electrophoresis. The nucleotide sequences of all PCR primers are listed in Table 1 . All primers and probes were synthesized by the Department of Biochemistry and Molecular Biology, University of New Mexico.
Specific probe hybridization and bead capture of fluorescent PCR products
Oligonucleotide probes specific to the junctional regions of the amplified fusion gene transcripts of interest were synthesized by phosphoramidite chemistry with a fluorescent moiety (eg 6-FAM or CY3) attached at the 5Ј end. The sequences of all hybridization probes are shown in Table 1 . For fluorescent probe hybridization, 10 l of the final RT-PCR product was mixed with 10 pmol of the corresponding 6-FAM or CY3 labeled probe in a 0.5 ml PCR tube (approximate total volume 12-15 l, depending on probe concentration). The hybridization reactions were performed in the thermal cycler by denaturing the PCR products at 95°C for 5 min, followed by a 60-65°C probe annealing for 15 min. Sample tubes were rapidly cooled to 4°C. The volume of hybridization product was then Leukemia added to 10 l of 0.5% streptavidin coated 6.0-8.0 m polystyrene beads (SVP-60-5, Spherotech Inc, Libertyville, IL, USA) and incubated at room temperature for 1 h. The beads were subsequently spun at high speed in a microcentrifuge for 15 s, the supernatant discarded and the beads resuspended in 750 l of buffer solution (100 mM Tris, 300 mM NaCl) in a 5 ml volume borosilicate collection tube. To enhance the maximum dilutional sensitivity of the fluorescent assay, a second 10 l aliquot of the PCR products was further purified using a spin column (MinElute PCR Purification Kit; Qiagen) to remove excess biotinylated primers, then subjected to the fluorescent probe hybridization reaction as described.
For comparison with the more traditional probe hybridization method of post-PCR analysis, the reverse transcription polymerase chain reactions were also carried out with unmodified (non-biotinylated) primers followed by gel electrophoresis, Southern blot transfer and junction-specific oligoprobe hybridization. The same oligonucleotide probe sequences in Table 1 were prepared instead with a 5Ј end biotin label to enable subsequent chemiluminescent detection of specific RT-PCR products on radiographic film, as previously described. 7 
Flow cytometric analysis
Sample tubes were analysed on a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA) using a 488 nm laser excitation. Two-color compensation was performed where necessary. For data analysis, the mean fluorescence intensity values of the test samples were compared against negative controls (non-specific RNA template and/or no RNA template). A mean fluorescence shift above 10 1 (log scale) was considered positive and below this value, negative.
Results and discussion
The t(1;19) abnormality in pediatric acute lymphoblastic leukemia is a translocation resulting essentially in a single breakpoint-fusion event with one chimeric E2A-PBX1 fusion transcript, [8] [9] [10] and is thus relatively easily amplified by RT-PCR. The 697 cell line bearing this translocation was used as the prototype to develop and test our methodology, which is schematically depicted in Figure 1 . Following experimental optimization, 15 blinded patient samples either positive or negative for the E2A-PBX1 fusion were evaluated. Among these, six were found to be positive and nine were negative for the E2A-PBX1 transcript by the PCR-bead capture-flow cytometric method, in complete concordance with prior results obtained from equivalent RT-PCR followed by standard Southern blot hybridization using an E2A-PBX1 biotinylated junction probe (data not shown). To determine the relative sensitivity of the assay, serial dilutions of RNA from cell line 697 in RNA from cell line SUP-T1 were examined. To maximise the relative sensitivity of the assay, a 10 l aliquot of the PCR products was also purified by spin column and the eluate used for subsequent probe hybridization and bead capture. Not surprisingly, a greater sensitivity (у50-fold increase) was observed with the purified PCR product, owing to removal of excess biotinylated PBX1 primer, which would otherwise compete for streptavidin binding sites on the beads. Results of this analysis for the E2A-PBX1 fusion are shown in Figure 2 , demonstrating the agarose gel electrophoresis bands and the corresponding post-PCR fluorescent dot plots. A dilutional Schematic of fluorescent probe-bead capture method for post-PCR analysis of leukemia-associated fusion transcripts. Polymerase chain reaction encompassing the fusion junction region of interest is carried out using a standard forward (sense) primer and 5Ј biotinylated reverse (antisense) primer, as shown in (a). An aliquot of PCR products is then hybridized in solution with a 5Ј fluorescently labeled junction-specific oligoprobe (b). The probe + PCR product complex is captured on to streptavidin-coated polystyrene beads (c). Detection of fluorescent signal is achieved by flow cytometry of the beads. Samples lacking the particular gene fusion will not generate specific PCR products and will not have a specific site for stringent probe hybridization and so no fluorescent signal will be obtained from the beads. Procedural details are provided in the text. sensitivity of 1 in 5 × 10 5 (equivalent to approximately 2 pg target RNA) is evidently detected by the PCR-bead captureflow cytometric method (Figure 2, lanes 3-10) , without nonspecific fluorescence in the negative controls (Figure 2, lanes  1 and 2) .
Subsequently, we applied this method to detect the t(9;22)-associated BCR-ABL fusion characteristic of CML and a subset of pediatric and adult acute lymphoblastic leukemia (Ph 1 ALL). 11 This more complex translocation provided a relevant basis for developing and testing the RT-PCR, fluorescent probe and flow cytometric analysis in a 'multiplex' format. Optimization of the PCR assay was accomplished using cell line sources producing the three BCR-ABL fusion mRNA types, respectively. Primers to detect each of the three chimeric transcripts (B2 and E1 forward with A2 reverse, Table 1) were combined in one sample tube for multiplex 'one-step' RT-PCR. Next, dual color (6-FAM and CY3 labeled) probe hybridizations for B3-A2 and B2-A2 transcripts, respectively, were performed simultaneously in one reaction tube, while the E1-A2 probe reaction (6-FAM) was carried out separately. Following these initial experiments, a group of BCR-ABL-positive or -negative patient samples was randomly selected and tested as 'unknowns'. These included four B3-A2, two B2-A2 and one E1-A2 type fusions (comprising three diagnostic and four post-therapy samples), as well as three BCR-ABL negative cases. These data are shown in Figure 3 and indicate that cell line or diagnostic patient samples with high BCR-ABL transcript abundance are unequivocally detected on the agarose gel (upper panel, lanes 4, 5, 8 and 11). However, the agarose gel image in Figure 3 also illustrates of the presence of low intensity, non-specific PCR bands of similar size in BCR-ABLpositive post-therapy samples (eg upper panel, lanes 6, 7, 9 and 10) and negative control samples (upper panel, lanes 12-14) alike. Post-PCR analysis is thus required to achieve assay specificity for these samples. Southern blot hybridization of the PCR products using junction-specific oligoprobes and chemiluminescent detection confirms the presence and type of BCR-ABL fusion mRNA in positive samples, with variable probe hybridization intensities generally correlating with the level of amplified transcript in individual cases (Figure 3 To this end, using a non-multiplexed single primer set RT-PCR, we have determined the detection sensitivity for the B3-A2 fusion transcript in cell line K562 to be approximately one cell in 5 × 10 4 background cells with the fluorescent assay, even without the pre-hybridization spin column enhancement step (Figure 4) . Notably however, the CY3-labeled B2-A2 oligoprobe exhibited a weaker overall fluorescence intensity in diagnostic samples than the 6-FAM-labeled B3-A2 or E1-A2 probes, using the fixed 488 nm laser excitation of the flow cytometer ( Figure 3 , lower panel, lane 5), indicating some inherent variability in the nature of the fluorochromes employed. Finally, all sample runs in this study were also assessed for the presence of an internal control mRNA (segment of the beta2-microglobulin or E2A gene product) by RT-PCR and agarose gel electrophoresis to confirm reverse transcription fidelity and RNA integrity (data not shown).
Many laboratories perform post-PCR isotopic or non-isotopic Southern blot oligoprobe hybridization to detect a specific amplified target in a given PCR assay. Alternatively, nested (two-round) PCR is another well-recognized technique for increasing both the sensitivity and specificity of target detection, as well as minimising unwanted aspecific amplification products. However, both of these approaches are characterized by additional laborious or time-consuming manipulations and, in the case of nested PCR, may be prone to increased contamination risk, if thorough adherence to detail is not strictly followed. The methodology described her- ein provides a rapid and robust alternative means to achieve the same ends. Other investigators have described similar but non-identical uses of specialized beads to capture and analyze PCR products or non-amplified nucleic acid targets. [12] [13] [14] However, these analogous procedures are characterized by significantly more laborious or proprietary requirements for the generation of labeled PCR products or the analytic beads. Unlike these other approaches, our methodology first simplifies the chemical modifications of the oligonucleotide reagents to allow synthesis in most university or commercial molecular laboratories. Additionally, the PCR, hybridization and bead capture steps are straightforward and rapid, utilizing readily available and standardized components. In our hands, the entire PCR and post-PCR detection procedure can be accomplished in approximately 4 h following RNA isolation, substantially faster than standard blot and probe methods. Alternative detection approaches, such as the use of streptavidin-coated well plates and a fluorescent plate reader, could further extend the applicability of this general method to larger scale applications.
Leukemia
Of note, the hybridization probes employed in this study were designed to span the unique fusion junction regions of Detection sensitivity for B3-A2 type BCR-ABL fusion transcript using the fluorescent probe-bead capture methodology. K562 cell line cells harboring the B3-A2 type BCR-ABL fusion were diluted into donor buffy coat cells and RNA extracted. Single tube RT-PCR was carried out with B2 forward and A2 reverse primers ( , respectively. A fluorescent signal is detected at 1/5 × 10 4 dilution and was not present below this level, although spin column purification to remove excess biotin-labeled primers prior to probe hybridization was not performed in this experiment. The addition of the latter step would be expected to increase the limit of specific detection somewhat further (see text).
the target chimeric mRNAs (cDNAs) and to maintain calculated annealing temperatures above 60°C (using the 4[G+C] + 2[A+T] method). This typically resulted in a requirement for probe lengths of 21-23 bases. Nonetheless, it should be emphasized that junctional probe design may have limitations imposed by the inherent nucleotide sequence available and some aspects of this process are therefore empirical. In addition, the general method described here has some restrictions imposed by the range of fluorophores currently available for use in oligonucleotide synthesis. As a corollary, certain fluorescent dyes we have investigated may tend to relatively weak fluorescence intensity (eg CY3), or conversely, higher background (eg CY5) in particular applications (personal observations). Rather than provide a rigorous platform for the use of fluorescent detection of leukemic translocation PCR products, our data demonstrate 'proof of concept' and should stimulate continued optimization of this type of assay for more routine application. Undoubtedly, improvements in primer and probe design, fluorophore choice and the availability of dual laser fluorescent instrumentation should permit greater standardization of the approach presented in this study.
In conclusion, this novel analytic method is more rapid, simple and cost effective as compared to traditional RT-PCR with Southern blot hybridization for the detection of leukemia-specific translocation gene fusions. This technique can potentially be used in a multiplex format for rapid identification of prognostically important recurrent leukemic translocations in pediatric ALL and adult or pediatric AML at diagnosis. Alternative fluorescent technologies now exist for rapid, 'real-time' quantitative analysis of specific PCR fragments (eg ABI Prism 7700 Sequence Detection System ('TaqMan'), Foster City, CA, USA, or Roche LightCycler System, Indianapolis, IN, USA). [15] [16] [17] Although such approaches currently remain relatively costly and are not suitable for routine diagnostic screening, these methods have become increasingly well established in the minimal residual disease (MRD) setting. The technique we describe is based upon endpoint PCR product detection, yet is sufficiently sensitive (particularly if post-PCR removal of excess biotinylated primers is performed prior to fluorescent probe hybridization and bead attachment) to serve both for diagnostic purposes and possibly for screening of MRD samples. In the latter instance, our assay can potentially be used to direct individual patient samples to more quantitative MRD evaluation techniques as necessary. Comparison studies with real-time quantitative PCR to evaluate this potential role may therefore be of value in this regard.
